SCHEMBL2492356

SCHEMBL2492356

[CH2]c1ccccc1-c1ccccc1NCCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.46
PDE5A O76074 1/20 0.43
GCGR P47871 1/20 0.40
MAPT P10636 2/20 0.39
HTT P42858 2/20 0.39
SLC2A1 P11166 1/20 0.35
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
CASP1 P29466 2/20 0.33
POLB P06746 1/20 0.33
LIMK1 P53667 2/20 0.33
ALDH1A1 P00352 2/20 0.33
USP2 O75604 1/20 0.33
BRCA1 P38398 1/20 0.33
CASP7 P55210 1/20 0.33
APAF1 O14727 1/20 0.33
BCHE P06276 2/20 0.33
ACHE P22303 2/20 0.33
CA12 O43570 2/20 0.32
CA9 Q16790 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2494990 0.89 ALDH1A1 (0.44) IDO1PDE5AMAPTHTTMEN1
SCHEMBL2488749 0.86 IDO1 (0.41) IDO1PDE5AGCGRMAPTHTT
SCHEMBL2492695 0.85 MEN1 (0.45) IDO1MAPTHTTMEN1KMT2A
SCHEMBL7357539 0.84 IDO1 (0.47) IDO1PDE5AMAPTHTTSLC2A1
SCHEMBL25477578 0.79 MAPT (0.55) IDO1PDE5AGCGRMAPTHTT
SCHEMBL11512622 0.77 IDO1 (0.55) IDO1PDE5AMAPTHTTSLC2A1
SCHEMBL2489196 0.77 MEN1 (0.40) MAPTHTTMEN1KMT2ACASP1
SCHEMBL12984545 0.77 SMN1; SMN2 (0.49) IDO1PDE5AGCGRMAPTHTT
SCHEMBL1926387 0.75 L3MBTL1 (0.48) MAPTHTTALDH1A1APAF1BCHE
SCHEMBL2495564 0.74 MAPT (0.42) IDO1MAPTMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH IDO1 275/4885PDE5A 1953/4885GCGR 885/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 IDO1 267/4885PDE5A 2061/4885GCGR 808/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R IDO1 320/4885PDE5A 2070/4885GCGR 839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.